Our endocrine system is made up of the glands in our body that produce and release hormones. This includes the ovaries, testes, thyroid, parathyroid, adrenals, pituitary, pineal body, and pancreas. Cells that release hormones are also located in our gastrointestinal tract, heart, kidneys, and the placenta. Hormones are responsible for a variety of essential functions in our bodies. They affect our metabolism, growth, development, sexual and reproductive functions, as well as sleep, even our mood. Endocrine disruptors can imitate or block the actions of some hormones. They have the potential to negatively affect all those systems in our body affected by hormones. Some of the possible effects of endocrine disruptors include infertility, low birth weight, sexual dysfunction, early puberty, delayed puberty, obesity, heart disease and cancer.
There should be safe walking space in the city, according to a city based endocrinologistDiabetics who are advised a daily walk often complain that encroached footpaths and inadequate number of parks and other open spaces in Calcutta make it almost impossible for them to take their daily stroll, doctors said on Wednesday.
Hazzaa AlMansoori in space conducts experiments on board the ISS Image Credit: Instagram @mbrspacecentre What you need to know: Hazzaa AlMansoori conducts experiments in space. Dubai: UAE s first astronaut, Hazzaa AlMansoori, is conducting experiments in zero gravity onboard the International Space Station. Pictures of him conducting the experiments were shared on social media by Dubai s Mohammad Bin Rashid Space Centre (MBRSC) today.The MBRSC shared two pictures of the Emirati astronaut on Instagram, with the caption: Photos of #FirstUAEAstronaut Hazzaa AlMansoori on the International Space Station as he undergoes Osteology Experiment to study bone condition, body composition and the endocrine system in space flight and weighing his body mass as part of the experiment.
Hazzaa Al Mansoori on the ISS as he undergoes experiments to study bone condition, body composition and the endocrine system. Image Credit: Twitter Dubai: Sunday s live space to Earth call by Emirati astronaut Hazzaa AlMansoori onboard the International Space Station (ISS) with UAE students in Dubai was extra special as it kicked off just roughly five minutes after the ISS had flown past the Arabian Peninsula, specifically Oman.Hazzaa s live video call on Sunday started at around 2.43pm as the ISS passed over the Arabian Peninsula to further down south of the UAE, near Ibri in Oman at around 2.38pm, based on information from an ISS live tracker.
As the Detroit Free Press reports, the Aretha Franklin Fund for Neuroendocrine Cancer Research will support continued investigation into the rare form of pancreatic cancer Franklin faced at the end of her life. The neuroendocrine tumor (NET) which ultimately led to Franklin;s passing, occurs in only 7 percent of pancreatic cancer cases, and took the life of Apple co founder and longtime CEO Steve Jobs in 2011.The Aretha Franklin Fund for Neuroendocrine Cancer represents a partnership between the singer 's estate, the Detroit based Women 's Informal Network, and Boston 's Neuroendocrine Tumor Research Foundation (NETRF).
The researchers find this has caused thousands of potentially preventable emergency department visits and hospitalizations for hypoglycemia (low blood sugar).The study team, led by Dr. Rozalina McCoy, an endocrinologist and primary care physician at Mayo Clinic, sought to identify the real world implications of intensive glucose lowering therapy across the U.S.
To guide clinicians, patients, and researchers with evidence based recommendations in the management of diabetes, the American Diabetes Association (ADA) included a new section on diabetes technology in their 2019 Standards of Medical Care in Diabetes. A review published in the Annals of Internal Medicine outlines these technology guidelines, focusing on self monitoring of blood glucose and the use of continuous glucose monitors and automated insulin delivery systems.The term diabetes technology encompasses the devices, hardware, and software that are used to assist in the management of blood glucose levels. For the current recommendations, the ADA Professional Practice Committee searched MEDLINE through November 2018 and evaluated high quality studies, as well as incorporated feedback from the larger clinical community.
Findings from the new study published recently in the European Journal of Endocrinology through an article titled ;Effects of 6 Month Vitamin D Supplementation on Insulin Sensitivity and Secretion: A Randomized, Placebo Controlled Trial; suggest that high dose supplementation of vitamin D can improve glucose metabolism to help prevent the development and progression of diabetes.People at high risk of developing type 2 diabetes (prediabetes) can be identified by several risk factors including obesity or a family history of the disease. Although low vitamin D levels have previously been associated with an increased risk of developing type 2 diabetes, some studies have reported no improvement in metabolic function. However, these often had a low number of participants or included individuals with normal vitamin D levels at the start who were metabolically healthy, or who had long standing type 2 diabetes. Whether vitamin D supplementation has any beneficial effect in patients with prediabetes or with newly diagnosed diabetes, especially in those who have low vitamin D levels, remains uncertain.
More than 70 million people live with diabetes in India and according to a recent study published in the journal Lancet Diabetes amp; Endocrinology the number of type 2 diabetes patients alone will reach 98 million by 2030. So, it s no wonder that India is known as the diabetes capital of the world. Type 2 diabetes is a disease where your blood sugar levels become uncontrollably high. This happens when your cells are unable to efficiently use insulin, the hormone produced by your pancreas to convert sugar from your blood into energy. This condition is known as insulin. The regular line of treatment for this condition includes oral drugs and insulin shots. However, the cornerstone of managing diabetes is a healthy lifestyle including a diet full of green, leafy vegetables and a well planned fitness regime. Diabetologists and nutritionists recommend a green platter for people with type 2 diabetes because they are high in fibre. According to experts, green vegetables like spinach, broccoli and bottle gourd are especially effective in controlling blood sugar levels.
SAN FRANCISCO Race and age specific disparities may exist in patterns of treatment intensification for patients with type 2 diabetes, according to research presented at the American Diabetes Association 79th Scientific Sessions, held June 7 to 11, 2019.Prior research has found significant delays in intensifying treatment for patients with diabetes in clinical practice, but differences in clinical inertia based on sociodemographic factors are less clear. Researchers used data from the GE Centricity Electronic Medical Record database to identify patients who were receiving dual therapy with metformin and 1 other antihyperglycemic agent for 12 months. Patients were eligible for inclusion if their therapeutic regimens were further intensified (addition of another oral antihyperglycemic agent or initiation of insulin glucagon like peptide 1 receptor agonist) within 2 years after index date and a measurement of glycated hemoglobin (HbA1c) level was recorded within 6 months of intensification.
SAN FRANCISCO In low income patients with diabetes, regular onsite testing can lower hemoglobin A1c (HbA1c), reduce diabetes related complications, and lower healthcare costs in a public health setting, according to study results presented at the American Diabetes Association 79th Scientific Sessions, held June 7 to 11, 2019, in San Francisco, CaliforniaResearchers sought to examine the outcomes of a redesigned Diabetes Education and Care program at Denton County Public Health in Texas. The program chose to participate in the Medicaid Delivery System Reform Incentive Payment plan with the goal of securing funding for patients with diabetes and improving their quality of life. Patients with diabetes who had an HbA1c gt;9% were eligible for inclusion in the study.
Outcome based incentives and personalized health coaching is an effective strategy for the short term reduction of hemoglobin A1c (HbA1c) in youth with type 1 diabetes (T1D), according to study results presented at the American Diabetes Association 79th Scientific Sessions, held June 7 to 11, 2019.Researchers examined the effects of a 10 week clinical care pilot program on decreasing HbA1c in adolescents with suboptimal diabetes control. The program consisted of weekly no cost health coaching for study participants and or their caregivers. Health coaching, conducted by diabetes team members, was offered over telephone and email, and was individualized on the basis of the needs of the family. The program also featured an outcome based incentive: participants who completed the program and saw reductions in HbA1c measurements were entered into a drawing to win an iPad.
The American Heart Association (AHA) and Heart Failure Society (HFS) released a joint scientific statement summarizing the epidemiology, pathophysiology, and effects of type 2 diabetes (T2D) control on heart failure (HF) outcomes. The full report was published online in Circulation.1Epidemiology of T2D and HF
Facebook Share to TwitterTwitterTwitter Share to LinkedInLinkedInLinkedIn Share to WhatsAppWhatsAppWhatsApp Share to Pinterest Pinterest Pinterest By AuthorANI Published: 19th May 2019 4:16 pmUpdated: 19th May 2019 5:02 pmRepresentational ImageWashington D.C: Mothers who breastfeed their babies are less prone to heart diseases that develop later in life, a study has found.The findings of the study were presented at the European Society of Endocrinology annual meeting, ECE 2019.
The results of this Yale led trial are published in the New England Journal of Medicine.William Tamborlane, M.D., first author and pediatric endocrinologist at Yale, said the success of the new drug, liraglutide, will be transformational for youth with type 2 diabetes. He explained that metformin and insulin are the only drugs currently approved for the treatment of children and teens with the condition.
Irrfan, who is making comeback to the movies with Angrezi Medium after recovering from neuroendocrine tumour, will be playing a sweet shop owner in the film, a sequel to his 2017 hit Hindi Medium. The actor shared a picture from the set of the movie, which is currently being shot in Udaipur, Rajasthan.
Hopes that the male contraceptive pill may become a reality have increased after a trial of a once daily capsule has found no significant side effects.Researchers from the University of Washington presented their results at ENDO 19, the Endocrine Society s meeting, on the 24th of March in New Orleans. The trial involved 40 men, 10 received a placebo pill and 30 took 11 beta MNTDC capsules once daily for 28 days. The main focus of the trial being to assess the safety of the drug.
A study was conducted and published in Endocrine Society;s Journal of Clinical Endocrinology amp; Metabolism to investigate the relationship between blood sugar control in diabetes and the risk of non vertebral low trauma fractures.The researchers selected participants with newly diagnosed type 1 and type 2 diabetes from a UK based, primary care database. The study period was 21 years, ranging from 1995 to 2015. The participants were divided into two groups: cases and controls.
Irrfan, who has recently returned from London after undergoing treatment for Neuroendocrine Tumour, will soon start working on the sequel of his 2017 film Hindi Medium. The sequel will be called English Medium as the film will now include people from other ethnicities in the US. The film will take a leap and show Irrfan's daughter going to the US for higher studies.
The new pill, which works similarly to female contraception, passed initial safety tests and produced hormone responses consistent with effective birth control in 30 men, according to research presented by the Los Angeles Biomedical Research Institute and the University of Washington at the Endocrine Society;s annual meeting. (The study has not yet been published in a peer reviewed journal.) It;s early days for the drug mdash; which has not yet been submitted for approval by the Food and Drug Administration (FDA) mdash; but co principal investigator Dr. Christina Wang, lead researcher at LA BioMed, says it;s an important step toward effective, reversible male hormonal contraception. "In females you have many, many methods. You have the pill, you have the patch, you have the vaginal ring, you have intrauterine devices, injections, " Wang says. "In men there is nothing that is like hormonal contraception. The standard is not equal for the genders. "